Skip to main content
NVDA+1.53%AAPL-0.15%GOOGL+0.82%MSFT+1.38%AMZN+0.83%TSM+2.68%SPCX+6.20%META+2.22%AVGO+2.32%TSLA+2.71%SKHY+0.23%MU-0.90%BRK-B+0.56%LLY+1.02%AMD-0.46%JPM+0.16%WMT+0.44%ASMLa+0.28%V+1.85%XOM-0.02%JNJ-0.80%INTC-2.10%MA+1.90%0700.HK+0.43%ABBV+0.04%1398.HK0.00%CSCO-0.05%LRCX-0.77%AMAT-0.58%AP2d-0.01%ORCL+0.85%COST+0.39%CVX-0.22%CAT+1.09%BAC+0.73%KO+0.81%DELL-2.03%PG+0.27%UNH-0.28%HSBA.L+1.01%0005.HK+0.27%ARM-2.35%3988.HK0.00%GE-1.01%1816.HK+0.48%0857.HK+0.53%MS-0.07%PM+0.76%0939.HK-0.52%1288.HK+0.46%NZDMXN-0.75%AUDNZD+0.62%AUDCHF+0.59%EURNOK-0.57%EURAUD-0.55%AUDDKK+0.54%CHFNOK-0.50%NZDUSD-0.48%USDTHB+0.44%EURUSD-0.42%NZDSGD-0.42%EURCNH-0.42%GBPTRY+0.41%EURHKD-0.40%NZDCAD-0.40%USDDKK+0.39%GBPAUD-0.39%USDPLN+0.39%USDCHF+0.37%EURSGD-0.35%EURCAD-0.35%AUDJPY+0.34%GBPHKD+0.32%NZDJPY-0.32%NOKJPY+0.32%CHFSGD-0.30%EURJPY-0.29%EURZAR-0.29%CADCHF+0.29%GBPMXN-0.28%USDMXN-0.28%GBPNZD+0.26%EURSEK-0.25%PLNJPY-0.23%GBPUSD-0.22%CHFJPY-0.22%AUDCAD+0.20%EURGBP-0.20%CHFSEK-0.20%AUDSGD+0.19%USDJPY+0.17%USDILS+0.16%GBPSGD-0.15%USDSEK+0.15%USDNOK-0.15%GBPCAD-0.14%GBPCHF+0.14%AUDUSD+0.14%GBPZAR-0.12%SGDJPY+0.12%NZDCHF-0.11%USDCAD+0.09%USDZAR+0.08%EURCZK+0.08%GBPJPY-0.08%CADJPY+0.07%EURCHF-0.07%EURNZD+0.07%USDTRY+0.06%USDCOP-0.04%USDSGD+0.04%AUDNOK-0.03%USDCNH+0.02%EURPLN-0.02%EURDKK-0.01%USDHKD0.00%COTTON+2.52%UKOIL-2.12%USOIL-1.66%XAGUSD+0.98%GAGUSD+0.96%XPTUSD+0.78%HG1+0.74%W1-0.73%C1-0.65%XNGUSD+0.65%S1-0.54%GAUUSD-0.17%BTCUSD-1.39%ETHUSD+5.48%USDTUSD-0.03%XRPUSD-1.36%SOLUSD-2.64%TRXUSDT+0.27%ZECUSDT-2.79%DOGEUSD-2.34%XMRUSDT+1.43%LINKUSD+0.15%XLMUSD-5.41%BCHUSDT-1.44%UNIUSD-1.32%LTCUSD-5.42%SUIUSD-1.39%HBARUSDT-3.13%TONUSD+11.93%TAOUSDT-2.03%AAVEUSD+2.24%DOTUSDT-1.20%ICPUSDT+2.80%ONDOUSDT-2.09%WLDUSDT-2.28%ARBUSDT+0.63%JUPUSDT+3.11%ATOMUSDT+2.79%INJUSDT-1.72%STXUSDT-2.75%FETUSDT-0.31%SEIUSDT-2.76%PYTHUSDT-3.07%TIAUSDT-2.90%IMXUSDT-2.27%GRTUSDT-1.77%OPUSDT+0.89%WIFUSDT-0.04%IOTAUSDT+1.00%AXSUSDT-6.92%FARTCOINUSDT-2.18%POLUSDT-3.34%EOSUSDT+2.84%DYDXUSDT-1.70%GALAUSDT-2.89%ORDIUSDT-2.13%NOTUSDT-1.20%RONINUSDT-2.26%NVDA+1.53%AAPL-0.15%GOOGL+0.82%MSFT+1.38%AMZN+0.83%TSM+2.68%SPCX+6.20%META+2.22%AVGO+2.32%TSLA+2.71%SKHY+0.23%MU-0.90%BRK-B+0.56%LLY+1.02%AMD-0.46%JPM+0.16%WMT+0.44%ASMLa+0.28%V+1.85%XOM-0.02%JNJ-0.80%INTC-2.10%MA+1.90%0700.HK+0.43%ABBV+0.04%1398.HK0.00%CSCO-0.05%LRCX-0.77%AMAT-0.58%AP2d-0.01%ORCL+0.85%COST+0.39%CVX-0.22%CAT+1.09%BAC+0.73%KO+0.81%DELL-2.03%PG+0.27%UNH-0.28%HSBA.L+1.01%0005.HK+0.27%ARM-2.35%3988.HK0.00%GE-1.01%1816.HK+0.48%0857.HK+0.53%MS-0.07%PM+0.76%0939.HK-0.52%1288.HK+0.46%NZDMXN-0.75%AUDNZD+0.62%AUDCHF+0.59%EURNOK-0.57%EURAUD-0.55%AUDDKK+0.54%CHFNOK-0.50%NZDUSD-0.48%USDTHB+0.44%EURUSD-0.42%NZDSGD-0.42%EURCNH-0.42%GBPTRY+0.41%EURHKD-0.40%NZDCAD-0.40%USDDKK+0.39%GBPAUD-0.39%USDPLN+0.39%USDCHF+0.37%EURSGD-0.35%EURCAD-0.35%AUDJPY+0.34%GBPHKD+0.32%NZDJPY-0.32%NOKJPY+0.32%CHFSGD-0.30%EURJPY-0.29%EURZAR-0.29%CADCHF+0.29%GBPMXN-0.28%USDMXN-0.28%GBPNZD+0.26%EURSEK-0.25%PLNJPY-0.23%GBPUSD-0.22%CHFJPY-0.22%AUDCAD+0.20%EURGBP-0.20%CHFSEK-0.20%AUDSGD+0.19%USDJPY+0.17%USDILS+0.16%GBPSGD-0.15%USDSEK+0.15%USDNOK-0.15%GBPCAD-0.14%GBPCHF+0.14%AUDUSD+0.14%GBPZAR-0.12%SGDJPY+0.12%NZDCHF-0.11%USDCAD+0.09%USDZAR+0.08%EURCZK+0.08%GBPJPY-0.08%CADJPY+0.07%EURCHF-0.07%EURNZD+0.07%USDTRY+0.06%USDCOP-0.04%USDSGD+0.04%AUDNOK-0.03%USDCNH+0.02%EURPLN-0.02%EURDKK-0.01%USDHKD0.00%COTTON+2.52%UKOIL-2.12%USOIL-1.66%XAGUSD+0.98%GAGUSD+0.96%XPTUSD+0.78%HG1+0.74%W1-0.73%C1-0.65%XNGUSD+0.65%S1-0.54%GAUUSD-0.17%BTCUSD-1.39%ETHUSD+5.48%USDTUSD-0.03%XRPUSD-1.36%SOLUSD-2.64%TRXUSDT+0.27%ZECUSDT-2.79%DOGEUSD-2.34%XMRUSDT+1.43%LINKUSD+0.15%XLMUSD-5.41%BCHUSDT-1.44%UNIUSD-1.32%LTCUSD-5.42%SUIUSD-1.39%HBARUSDT-3.13%TONUSD+11.93%TAOUSDT-2.03%AAVEUSD+2.24%DOTUSDT-1.20%ICPUSDT+2.80%ONDOUSDT-2.09%WLDUSDT-2.28%ARBUSDT+0.63%JUPUSDT+3.11%ATOMUSDT+2.79%INJUSDT-1.72%STXUSDT-2.75%FETUSDT-0.31%SEIUSDT-2.76%PYTHUSDT-3.07%TIAUSDT-2.90%IMXUSDT-2.27%GRTUSDT-1.77%OPUSDT+0.89%WIFUSDT-0.04%IOTAUSDT+1.00%AXSUSDT-6.92%FARTCOINUSDT-2.18%POLUSDT-3.34%EOSUSDT+2.84%DYDXUSDT-1.70%GALAUSDT-2.89%ORDIUSDT-2.13%NOTUSDT-1.20%RONINUSDT-2.26%
AM

Amgen Inc. (AMGN)

NASDAQ • Healthcare

$403.48
+$0.43 (+0.1%)
Market open

October 5, 2026 at 17:50 UTC

Open$410.16
Previous Close$403.04
Day Range$401.96 - $410.16
Avg. Volume (3M)3.4M
Market Cap$215.8B
P/E Ratio24.8
52 Week Range
$288$447.03
Next EarningsIn 29 daysNov 3, 2026

Interactive Chart

17:50:11 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$10B100%
Gross Profitminus cost of goods$7.2B72%
Operating Incomeminus R&D and overhead$3.5B35%
Net Incomeminus taxes and the rest$2.3B24%

In plain terms: out of every $100 in revenue, Amgen Inc. keeps $24 as net profit.

Fundamentals & Financials

Revenue (TTM)
$38.1B
Net Income (TTM)
$8.7B
EPS (TTM)
$16.22
ROA (TTM)
9.14%
Current Ratio
1.37
Dividend Yield
0.7%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+11.8%Q1 2026$5.29
+8.0%Q2 2026$5.15
+11.9%Q3 2026$6.29
Next

Nov 3

in 29 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +11.9%

Amgen beat consensus on both the top and bottom line in the second fiscal quarter of 2026, reported on August 4 based on preliminary results, with revenue of about $10.1 billion topping the about $9.4 billion estimate by 7% and adjusted EPS of $6.29 beating the $5.64 consensus by 12%. Revenue rose 10% from about $9.2 billion a year ago, while net income climbed 66% to about $2.4 billion from about $1.4 billion and adjusted EPS was up 5% from $6.02. Operating income reached about $3.5 billion as operating margin held about 35%, with gross margin near 72%. Operating cash flow was about $4.0 billion, the company paid about $1.4 billion in dividends, and consensus for the next period calls for EPS of $5.77 on revenue of $9.72 billion.

Next report — what to expect

Amgen Inc. (AMGN) reports next on November 3, 2026. Wall Street expects EPS of $5.79 on revenue of $10.05 billion. For trailing context, revenue grew +9.7% year over year last quarter. Amgen has beaten EPS in 8 of 8 most recent quarters, keeping focus on delivery versus these consensus targets.

View full earnings history

About Amgen Inc.

Amgen Inc. develops, manufactures, and delivers human medicines as a large-cap biotechnology and biopharmaceutical company listed on NASDAQ as AMGN. Its portfolio spans inflammation, cancer and blood disorders, bone health, cardiovascular disease, kidney-related care, and neuroscience, and it generated $36.7 billion of revenue in FY2025.

Name
Amgen Inc.
CEO
Robert A. Bradway
Website
www.amgen.com
Industry
Healthcare
Year Founded
1980
Employees
31,500

Today's Snapshot

AI-generated

AMGN is slightly lower at 401.75 so far today, in line with a flat sector. Cantor Fitzgerald analyst reiterates a Neutral rating on Amgen, with a $400 price target.

Trading Volume

Below 10d avg (2.8M)

783.7K

vs S&P 500 Today

Underperforming Market

-0.78%

Updated: October 5, 2026 at 16:39 UTC

AMGN Headlines

Novartis heart drug trial miss hits shares

September 7, 2026

3 min read

Amgen reports material cyber data breach

July 31, 2026

3 min read

IBM and Honeywell lead Dow intraday advance

May 21, 2026

2 min read

Big Pharma Updates: Trials, Deals and Ratings

April 27, 2026

6 min read
View All News

Technical Indicators

4 Buy2 Neutral2 Sell
AMGN shows a cautiously bullish profile with the stock trading above the intraday VWAP and well above its 200-day averages, which supports a longer-term constructive backdrop. Momentum is mixed but leaning positive as the MACD is in buy territory and short-term momentum readings show some lift, while OBV indicates accumulation. Trend strength is moderate (ADX just under 25) and volatility is muted (ATR about 2.5%), suggesting measured buying rather than a breakout surge. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$368.42 - $407.62
    Buy
  • RSI (14)47.92
    Neutral
  • Stochastic %K (14, 3, 3)57.78
    Neutral
  • MACD Level (12, 26)0.54
    Buy

Peers & Related Assets

MRKMerck & Co., Inc.
$144.3+0.3%
NVSNovartis AG
$140.41-0.4%
GILDGilead Sciences, Inc.
$143.98-0.5%
PFEPfizer Inc.
$27.42-1.4%
DHRDanaher Corporation
$214.06+1.1%
BMYBristol-Myers Squibb Company
$58.93-3.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.